WO2005112996B1 - 1,4 o-verknüpfte saccharose-derivate zur stabilisierung von antikörpern oder antikörper-derivaten - Google Patents
1,4 o-verknüpfte saccharose-derivate zur stabilisierung von antikörpern oder antikörper-derivatenInfo
- Publication number
- WO2005112996B1 WO2005112996B1 PCT/EP2005/004807 EP2005004807W WO2005112996B1 WO 2005112996 B1 WO2005112996 B1 WO 2005112996B1 EP 2005004807 W EP2005004807 W EP 2005004807W WO 2005112996 B1 WO2005112996 B1 WO 2005112996B1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- sucrose
- composition
- derivative
- linked
- antibody
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39591—Stabilisation, fragmentation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
Abstract
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05737678A EP1784215A1 (de) | 2004-05-10 | 2005-05-04 | 1,4 o-verknüpfte saccharose-derivate zur stabilisierung von antikörpern oder antikörper-derivaten |
CA002565019A CA2565019A1 (en) | 2004-05-10 | 2005-05-04 | 1,4 o-linked saccharose derivatives for stabilizing antibodies or antibody derivatives |
JP2007512008A JP2007536314A (ja) | 2004-05-10 | 2005-05-04 | 抗体又は抗体誘導体を安定化させるための1,4o−結合型サッカロース誘導体 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004022927A DE102004022927A1 (de) | 2004-05-10 | 2004-05-10 | 1,4 O-verknüpfte Saccharose-Derivate zur Stabilisierung von Antikörpern oder Antikörper-Derivaten |
DE102004022927.9 | 2004-05-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005112996A1 WO2005112996A1 (de) | 2005-12-01 |
WO2005112996B1 true WO2005112996B1 (de) | 2006-01-26 |
Family
ID=34966086
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2005/004807 WO2005112996A1 (de) | 2004-05-10 | 2005-05-04 | 1,4 o-verknüpfte saccharose-derivate zur stabilisierung von antikörpern oder antikörper-derivaten |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1784215A1 (de) |
JP (1) | JP2007536314A (de) |
KR (1) | KR20070057086A (de) |
CA (1) | CA2565019A1 (de) |
DE (1) | DE102004022927A1 (de) |
TW (1) | TW200605905A (de) |
WO (1) | WO2005112996A1 (de) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8883979B2 (en) | 2012-08-31 | 2014-11-11 | Bayer Healthcare Llc | Anti-prolactin receptor antibody formulations |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7727962B2 (en) | 2004-05-10 | 2010-06-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Powder comprising new compositions of oligosaccharides and methods for their preparation |
US7611709B2 (en) | 2004-05-10 | 2009-11-03 | Boehringer Ingelheim Pharma Gmbh And Co. Kg | 1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives |
US7723306B2 (en) | 2004-05-10 | 2010-05-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Spray-dried powder comprising at least one 1,4 O-linked saccharose-derivative and methods for their preparation |
EP2077132A1 (de) | 2008-01-02 | 2009-07-08 | Boehringer Ingelheim Pharma GmbH & Co. KG | Abgabevorrichtung, Aufbewahrungsvorrichtung und Verfahren zur Abgabe einer Formulierung |
JP5670421B2 (ja) | 2009-03-31 | 2015-02-18 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | コンポーネント表面のコーティング方法 |
JP5763053B2 (ja) | 2009-05-18 | 2015-08-12 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | アダプタ、吸入器具及びアトマイザ |
US10016568B2 (en) | 2009-11-25 | 2018-07-10 | Boehringer Ingelheim International Gmbh | Nebulizer |
JP5715640B2 (ja) | 2009-11-25 | 2015-05-13 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ネブライザ |
WO2011064163A1 (en) | 2009-11-25 | 2011-06-03 | Boehringer Ingelheim International Gmbh | Nebulizer |
US9943654B2 (en) | 2010-06-24 | 2018-04-17 | Boehringer Ingelheim International Gmbh | Nebulizer |
WO2012130757A1 (de) | 2011-04-01 | 2012-10-04 | Boehringer Ingelheim International Gmbh | Medizinisches gerät mit behälter |
US9827384B2 (en) | 2011-05-23 | 2017-11-28 | Boehringer Ingelheim International Gmbh | Nebulizer |
WO2013152894A1 (de) | 2012-04-13 | 2013-10-17 | Boehringer Ingelheim International Gmbh | Zerstäuber mit kodiermitteln |
WO2015018904A1 (en) | 2013-08-09 | 2015-02-12 | Boehringer Ingelheim International Gmbh | Nebulizer |
EP2835146B1 (de) | 2013-08-09 | 2020-09-30 | Boehringer Ingelheim International GmbH | Zerstäuber |
PL3139979T3 (pl) | 2014-05-07 | 2023-12-27 | Boehringer Ingelheim International Gmbh | Jednostka, nebulizator i sposób |
JP6745225B2 (ja) | 2014-05-07 | 2020-08-26 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 容器、表示デバイス、及びネブライザ |
ES2874029T3 (es) | 2014-05-07 | 2021-11-04 | Boehringer Ingelheim Int | Nebulizador |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989011297A1 (en) * | 1988-05-27 | 1989-11-30 | Centocor, Inc. | Freeze-dried formulation for antibody products |
JPH0776527A (ja) * | 1993-06-28 | 1995-03-20 | Hayashibara Biochem Lab Inc | 半固形製剤とその製造方法 |
AU716785B2 (en) * | 1995-07-27 | 2000-03-09 | Genentech Inc. | Stabile isotonic lyophilized protein formulation |
TW403653B (en) * | 1995-12-25 | 2000-09-01 | Otsuka Pharma Co Ltd | Dry compositions |
KR100632312B1 (ko) * | 1997-10-23 | 2007-05-14 | 미쯔비시 웰 파마 가부시키가이샤 | 실온저장가능한정맥내주사용면역글로불린제제 |
DE69735600T2 (de) * | 1997-11-26 | 2007-01-25 | Universal Preservation Technologies, Inc., San Diego | Konservierung empfindlicher biologischer proben durch verglasung |
WO2000066160A1 (fr) * | 1999-04-28 | 2000-11-09 | Yamanouchi Pharmaceutical Co., Ltd. | Composition medicamenteuse parenterale a fragment d'anticorps monoclonal humanise et procede de stabilisation |
JP2004515467A (ja) * | 2000-08-07 | 2004-05-27 | ネクター セラピューティックス | 吸入可能な、噴霧乾燥した、最少の凝集物を有する4−ヘリックスバンドルタンパク質粉末 |
AU3664102A (en) * | 2000-12-01 | 2002-06-11 | Battelle Memorial Institute | Method for stabilizing biomolecules in liquid formulations |
JP2003055257A (ja) * | 2001-08-10 | 2003-02-26 | Nihon Pharmaceutical Co Ltd | 安定な血液凝固第xiii因子製剤 |
GB2382528B (en) * | 2001-11-12 | 2004-05-05 | Mars Inc | A consumable composition for the development of a healthy gastrointestinal tract |
WO2003080027A1 (en) * | 2002-03-20 | 2003-10-02 | Elan Pharma International, Ltd. | Nanoparticulate compositions of angiogenesis inhibitors |
-
2004
- 2004-05-10 DE DE102004022927A patent/DE102004022927A1/de not_active Withdrawn
-
2005
- 2005-05-04 CA CA002565019A patent/CA2565019A1/en not_active Abandoned
- 2005-05-04 JP JP2007512008A patent/JP2007536314A/ja active Pending
- 2005-05-04 WO PCT/EP2005/004807 patent/WO2005112996A1/de active Application Filing
- 2005-05-04 EP EP05737678A patent/EP1784215A1/de not_active Withdrawn
- 2005-05-04 KR KR1020067025976A patent/KR20070057086A/ko not_active Application Discontinuation
- 2005-05-09 TW TW094114825A patent/TW200605905A/zh unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8883979B2 (en) | 2012-08-31 | 2014-11-11 | Bayer Healthcare Llc | Anti-prolactin receptor antibody formulations |
Also Published As
Publication number | Publication date |
---|---|
CA2565019A1 (en) | 2005-12-01 |
EP1784215A1 (de) | 2007-05-16 |
WO2005112996A1 (de) | 2005-12-01 |
TW200605905A (en) | 2006-02-16 |
JP2007536314A (ja) | 2007-12-13 |
KR20070057086A (ko) | 2007-06-04 |
DE102004022927A1 (de) | 2005-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005112996B1 (de) | 1,4 o-verknüpfte saccharose-derivate zur stabilisierung von antikörpern oder antikörper-derivaten | |
DE60127175T2 (de) | Lagerstabile pulverzusammensetzungen mit interleukin-4 rezeptor | |
DE69631881T2 (de) | Pulmonale verabreichung von medikamenten in aerosolform | |
EP1658047B1 (de) | Sprühgetrocknete amorphe pulver mit geringer restfeuchte und guter lagerstabilität | |
DE69530519T2 (de) | Parathyroidhormon pth enthaltende therapeutische zubereitung zur inhalation | |
DE69631159T2 (de) | Pulver und deren verwendung in trockenpulverinhalatoren | |
EP1381385B1 (de) | Zinkfreie und zinkarme insulinzubereitungen mit verbesserter stabilität | |
DE69821872T2 (de) | Teriparatidhaltige stabilisierte Lösungen | |
DE69631119T2 (de) | Pulver zur verwendung in trockenpulverinhalatoren | |
DE69938452T2 (de) | Sprüh-getrocknete Insulin-Mikropartikel zur Inhalation | |
DE69533294T2 (de) | Pulverformulierungen, die Melezitose als Verdünnungsmittel enthalten | |
US7056886B2 (en) | GLP-2 formulations | |
DE60127407T2 (de) | Hochwirksame verabreichung eines aerosols mit hoher therapeutischer masse | |
WO1994014465A1 (de) | Stabile lyophilisierte pharmazeutische zubereitungen von g-csf | |
WO2003053465A2 (de) | Lyophilisierte zubereitung enthaltend antikörper gegen den egf-rezeptor | |
DE4208258A1 (de) | Ciclosporin zur pulmonalen verabreichung | |
EP1778188A1 (de) | Zumindest ein 1,4 o-verknüpftes saccharose-derivat enthaltende sprühgetrocknete pulver und verfahren zu deren herstellung | |
EP2679239A1 (de) | Pharmazeutische Zusammensetzung zur Behandlung der durch Sauerstoffarmut und verringerten Luftdruck vermittelten pulmonalen Form der Höhenkrankheit | |
EP0722719B1 (de) | Verfahren zur Herstellung von Flavano-Lignan-Zubereitungen | |
KR20040074052A (ko) | 증가된 용해도를 갖는 플라바노리그난 제제 | |
DE60017444T2 (de) | Pharmazeutische formulierungen auf basis fester dispersionen | |
WO2002017882A1 (de) | Feste peptidzubereitungen für die inhalation und deren herstellung | |
JP2003533472A (ja) | 吸入用インスリン製剤 | |
DE69531166T2 (de) | Arzneistoff zur erleichterung der durch immunsuppressiva verursachten nebenwirkungen | |
NL8202773A (nl) | Apap-antizuur-samenstelling. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
B | Later publication of amended claims |
Effective date: 20051122 |
|
DPEN | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2005737678 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2565019 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007512008 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020067025976 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 2005737678 Country of ref document: EP |